tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Summit Therapeutics initiated with a Peer Perform at Wolfe Research
PremiumThe FlySummit Therapeutics initiated with a Peer Perform at Wolfe Research
1M ago
Positive Outlook for Summit Therapeutics Amid Strategic Clinical Advancements
Premium
Ratings
Positive Outlook for Summit Therapeutics Amid Strategic Clinical Advancements
1M ago
Summit Therapeutics Reports Positive Phase III Trial Results
Premium
Company Announcements
Summit Therapeutics Reports Positive Phase III Trial Results
1M ago
Summit Therapeutics’ Phase 3 Study on Ivonescimab: A Potential Game-Changer in NSCLC Treatment
PremiumCompany AnnouncementsSummit Therapeutics’ Phase 3 Study on Ivonescimab: A Potential Game-Changer in NSCLC Treatment
2M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
Buy Rating for Summit Therapeutics Driven by Promising HARMONi-6 Trial Results and Improved Safety Profile
Premium
Ratings
Buy Rating for Summit Therapeutics Driven by Promising HARMONi-6 Trial Results and Improved Safety Profile
2M ago
Summit Therapeutics to sell 26.68M shares at $18.74 in private placement
PremiumThe FlySummit Therapeutics to sell 26.68M shares at $18.74 in private placement
2M ago
Summit Therapeutics price target lowered to $40 from $50 at H.C. Wainwright
Premium
The Fly
Summit Therapeutics price target lowered to $40 from $50 at H.C. Wainwright
2M ago
Summit Therapeutics price target raised to $16 from $13 at Barclays
Premium
The Fly
Summit Therapeutics price target raised to $16 from $13 at Barclays
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100